These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21855148

  • 21. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 22. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C, Hopfer H, Danner D, Schaller M, Mihatsch MJ, Trendelenburg M.
    Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
    [Abstract] [Full Text] [Related]

  • 23. Are anti-C1q antibodies different from other SLE autoantibodies?
    Pickering MC, Botto M.
    Nat Rev Rheumatol; 2010 Aug; 6(8):490-3. PubMed ID: 20421881
    [Abstract] [Full Text] [Related]

  • 24. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis.
    Tan Y, Song D, Wu LH, Yu F, Zhao MH.
    BMC Nephrol; 2013 Mar 19; 14():63. PubMed ID: 23510032
    [Abstract] [Full Text] [Related]

  • 25. Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity.
    Bernstein KA, Kahl LE, Balow JE, Lefkowith JB.
    Clin Exp Immunol; 1994 Oct 19; 98(1):60-5. PubMed ID: 7923886
    [Abstract] [Full Text] [Related]

  • 26. Lupus nephritis: the central role of nucleosomes revealed.
    Mortensen ES, Fenton KA, Rekvig OP.
    Am J Pathol; 2008 Feb 19; 172(2):275-83. PubMed ID: 18187568
    [Abstract] [Full Text] [Related]

  • 27. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis.
    van Bruggen MC, Kramers C, Walgreen B, Elema JD, Kallenberg CG, van den Born J, Smeenk RJ, Assmann KJ, Muller S, Monestier M, Berden JH.
    Nephrol Dial Transplant; 1997 Jan 19; 12(1):57-66. PubMed ID: 9027774
    [Abstract] [Full Text] [Related]

  • 28. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.
    Trouw LA, Daha MR.
    Expert Opin Biol Ther; 2005 Feb 19; 5(2):243-51. PubMed ID: 15757386
    [Abstract] [Full Text] [Related]

  • 29. Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.
    Thanei S, Trendelenburg M.
    J Leukoc Biol; 2017 Feb 19; 101(2):481-491. PubMed ID: 27630215
    [Abstract] [Full Text] [Related]

  • 30. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H, Ekblom-Kullberg S, Miettinen A.
    Rheumatol Int; 2012 Aug 19; 32(8):2445-51. PubMed ID: 21706294
    [Abstract] [Full Text] [Related]

  • 31. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis.
    Mannik M, Wener MH.
    Arthritis Rheum; 1997 Aug 19; 40(8):1504-11. PubMed ID: 9259432
    [Abstract] [Full Text] [Related]

  • 32. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A, Pipi E, Soufleros K.
    Ann N Y Acad Sci; 2009 Sep 19; 1173():243-51. PubMed ID: 19758158
    [Abstract] [Full Text] [Related]

  • 33. Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review.
    Gatto M, Iaccarino L, Ghirardello A, Punzi L, Doria A.
    J Autoimmun; 2016 May 19; 69():1-11. PubMed ID: 26879422
    [Abstract] [Full Text] [Related]

  • 34. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 35. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E, Tănăsescu C, Bălănescu P, Olteanu R, Badea C, Petruţescu B, Grancea C, Vagu C, Bleotu C, Ruţă S, Ardeleanu C.
    Rom J Intern Med; 2010 Apr 13; 48(2):159-63. PubMed ID: 21428180
    [Abstract] [Full Text] [Related]

  • 36. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.
    Meyer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, Dieudé P, Chollet-Martin S.
    Arthritis Res Ther; 2009 Apr 13; 11(3):R87. PubMed ID: 19515233
    [Abstract] [Full Text] [Related]

  • 37. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K, Niemir ZI, Polcyn-Adamczak M.
    Pol Arch Med Wewn; 2011 Sep 13; 121(9):287-95. PubMed ID: 21860370
    [Abstract] [Full Text] [Related]

  • 38. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
    Radanova M, Vasilev V, Deliyska B, Kishore U, Ikonomov V, Ivanova D.
    Immunobiology; 2012 Jul 13; 217(7):684-91. PubMed ID: 22209113
    [Abstract] [Full Text] [Related]

  • 39. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC, Wang CR, Liu MF, Chen FF, Liang CC.
    Asian Pac J Allergy Immunol; 2002 Dec 13; 20(4):223-7. PubMed ID: 12744622
    [Abstract] [Full Text] [Related]

  • 40. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies.
    Trouw LA, Seelen MA, Duijs JM, Benediktsson H, Van Kooten C, Daha MR.
    Clin Exp Immunol; 2003 Apr 13; 132(1):32-9. PubMed ID: 12653833
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.